Glen Harbor Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$12.9M Buy
119,034
+26,078
+28% +$2.72M 0.27% 77
2019
Q2
$9.05M Buy
92,956
+32,436
+54% +$2.96M 0.19% 109
2019
Q1
$5.51M Buy
60,520
+21,080
+53% +$1.89M 0.12% 173
2018
Q4
$3.59M Sell
39,440
-9,044
-19% -$845K 0.09% 225
2018
Q3
$4.77M Sell
48,484
-1,122
-2% -$104K 0.1% 208
2018
Q2
$4.25M Buy
49,606
+10,030
+25% +$838K 0.09% 208
2018
Q1
$3.17M Buy
39,576
+510
+1% +$42.1K 0.07% 229
2017
Q4
$3.15M Buy
39,066
+12,954
+50% +$1.04M 0.07% 237
2017
Q3
$2.03M Sell
26,112
-2,754
-10% -$229K 0.05% 286
2017
Q2
$2.56M Sell
28,866
-476
-2% -$40.1K 0.06% 254
2017
Q1
$2.36M Buy
29,342
+8,092
+38% +$632K 0.06% 271
2016
Q4
$1.51M Buy
+21,250
New +$1.67M 0.04% 310

Other funds holding MDT

Glen Harbor Capital Management's MDT Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Medtronic (MDT) stake by 28% in Q3 2019, buying an estimated $2.72M and bringing the position to 119,034 shares worth $12.9M. The position accounts for 0.27% of the portfolio, ranked #77.

Glen Harbor Capital Management first reported a position in MDT in Q4 2016 and has held it in 12 quarters since. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Glen Harbor Capital Management held 119,034 shares of Medtronic worth $12.9M as of Q3 2019.
  • Glen Harbor Capital Management bought 26,078 Medtronic shares in Q3 2019, an estimated $2.72M.
  • Medtronic made up 0.27% of Glen Harbor Capital Management's portfolio in Q3 2019, its #77 holding.
  • Glen Harbor Capital Management first reported a position in Medtronic in Q4 2016 and has held it in 12 quarters since.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.